                         SEQUENCE LISTING

<110>  Icosagen Cell Factory O
 
<120>  Bovine colostrum derived antibodies and uses thereof

<130>  11344-010WO1

<150>  US 63/160,833
<151>  2021-03-14

<160>  9     

<170>  PatentIn version 3.5

<210>  1
<211>  702
<212>  DNA
<213>  artificial sequence

<220>
<223>  Chemically synthesized


<220>
<221>  cDNA
<222>  (1)..(702)
<223>  SARS CoV-2 Spike protein receptor binding domain cDNA

<400>  1
gctagcaggg tgcagccaac cgagtctatc gtgcgctttc ctaatatcac aaacctgtgc       60

ccatttggcg aggtgttcaa cgcaacccgc ttcgccagcg tgtacgcctg gaataggaag      120

cggatcagca actgcgtggc cgactatagc gtgctgtaca actccgcctc tttcagcacc      180

tttaagtgct atggcgtgtc ccccacaaag ctgaatgacc tgtgctttac caacgtctac      240

gccgattctt tcgtgatcag gggcgacgag gtgcgccaga tcgcccccgg ccagacaggc      300

aagatcgcag actacaatta taagctgcca gacgatttca ccggctgcgt gatcgcctgg      360

aacagcaaca atctggattc caaagtgggc ggcaactaca attatctgta ccggctgttt      420

agaaagagca atctgaagcc cttcgagagg gacatctcta cagaaatcta ccaggccggc      480

agcacccctt gcaatggcgt ggagggcttt aactgttatt tcccactcca gtcctacggc      540

ttccagccca caaacggcgt gggctatcag ccttaccgcg tggtggtgct gagctttgag      600

ctgctgcacg ccccagcaac agtgtgcggc cccaagaagt ccaccaatct ggtgaagaac      660

aagtgcgtga acttcggatc cggccaccat caccatcacc ac                         702


<210>  2
<211>  234
<212>  PRT
<213>  artificial sequence

<220>
<223>  Chemically synthesized


<220>
<221>  MISC_FEATURE
<222>  (1)..(2)

<220>
<221>  DOMAIN
<222>  (3)..(228)
<223>  SARS CoV-2 Spike protein receptor binding domain of Wuhan variant

<220>
<221>  MISC_FEATURE
<222>  (229)..(234)

<400>  2

Ala Ser Arg Val Gln Pro Thr Glu Ser Ile Val Arg Phe Pro Asn Ile 
1               5                   10                  15      


Thr Asn Leu Cys Pro Phe Gly Glu Val Phe Asn Ala Thr Arg Phe Ala 
            20                  25                  30          


Ser Val Tyr Ala Trp Asn Arg Lys Arg Ile Ser Asn Cys Val Ala Asp 
        35                  40                  45              


Tyr Ser Val Leu Tyr Asn Ser Ala Ser Phe Ser Thr Phe Lys Cys Tyr 
    50                  55                  60                  


Gly Val Ser Pro Thr Lys Leu Asn Asp Leu Cys Phe Thr Asn Val Tyr 
65                  70                  75                  80  


Ala Asp Ser Phe Val Ile Arg Gly Asp Glu Val Arg Gln Ile Ala Pro 
                85                  90                  95      


Gly Gln Thr Gly Lys Ile Ala Asp Tyr Asn Tyr Lys Leu Pro Asp Asp 
            100                 105                 110         


Phe Thr Gly Cys Val Ile Ala Trp Asn Ser Asn Asn Leu Asp Ser Lys 
        115                 120                 125             


Val Gly Gly Asn Tyr Asn Tyr Leu Tyr Arg Leu Phe Arg Lys Ser Asn 
    130                 135                 140                 


Leu Lys Pro Phe Glu Arg Asp Ile Ser Thr Glu Ile Tyr Gln Ala Gly 
145                 150                 155                 160 


Ser Thr Pro Cys Asn Gly Val Glu Gly Phe Asn Cys Tyr Phe Pro Leu 
                165                 170                 175     


Gln Ser Tyr Gly Phe Gln Pro Thr Asn Gly Val Gly Tyr Gln Pro Tyr 
            180                 185                 190         


Arg Val Val Val Leu Ser Phe Glu Leu Leu His Ala Pro Ala Thr Val 
        195                 200                 205             


Cys Gly Pro Lys Lys Ser Thr Asn Leu Val Lys Asn Lys Cys Val Asn 
    210                 215                 220                 


Phe Gly Ser Gly His His His His His His 
225                 230                 


<210>  3
<211>  234
<212>  PRT
<213>  artificial sequence

<220>
<223>  Chemically synthesized


<220>
<221>  MISC_FEATURE
<222>  (1)..(2)

<220>
<221>  DOMAIN
<222>  (3)..(228)
<223>  SARS CoV-2 Spike protein receptor binding domain from Alpha 
       variant

<220>
<221>  MISC_FEATURE
<222>  (229)..(234)

<400>  3

Ala Ser Arg Val Gln Pro Thr Glu Ser Ile Val Arg Phe Pro Asn Ile 
1               5                   10                  15      


Thr Asn Leu Cys Pro Phe Gly Glu Val Phe Asn Ala Thr Arg Phe Ala 
            20                  25                  30          


Ser Val Tyr Ala Trp Asn Arg Lys Arg Ile Ser Asn Cys Val Ala Asp 
        35                  40                  45              


Tyr Ser Val Leu Tyr Asn Ser Ala Ser Phe Ser Thr Phe Lys Cys Tyr 
    50                  55                  60                  


Gly Val Ser Pro Thr Lys Leu Asn Asp Leu Cys Phe Thr Asn Val Tyr 
65                  70                  75                  80  


Ala Asp Ser Phe Val Ile Arg Gly Asp Glu Val Arg Gln Ile Ala Pro 
                85                  90                  95      


Gly Gln Thr Gly Lys Ile Ala Asp Tyr Asn Tyr Lys Leu Pro Asp Asp 
            100                 105                 110         


Phe Thr Gly Cys Val Ile Ala Trp Asn Ser Asn Asn Leu Asp Ser Lys 
        115                 120                 125             


Val Gly Gly Asn Tyr Asn Tyr Leu Tyr Arg Leu Phe Arg Lys Ser Asn 
    130                 135                 140                 


Leu Lys Pro Phe Glu Arg Asp Ile Ser Thr Glu Ile Tyr Gln Ala Gly 
145                 150                 155                 160 


Ser Thr Pro Cys Asn Gly Val Glu Gly Phe Asn Cys Tyr Phe Pro Leu 
                165                 170                 175     


Gln Ser Tyr Gly Phe Gln Pro Thr Tyr Gly Val Gly Tyr Gln Pro Tyr 
            180                 185                 190         


Arg Val Val Val Leu Ser Phe Glu Leu Leu His Ala Pro Ala Thr Val 
        195                 200                 205             


Cys Gly Pro Lys Lys Ser Thr Asn Leu Val Lys Asn Lys Cys Val Asn 
    210                 215                 220                 


Phe Gly Ser Gly His His His His His His 
225                 230                 


<210>  4
<211>  234
<212>  PRT
<213>  artificial sequence

<220>
<223>  Chemically synthesized


<220>
<221>  MISC_FEATURE
<222>  (1)..(2)

<220>
<221>  DOMAIN
<222>  (2)..(228)
<223>  SARS CoV-2 Spike protein receptor binding protein from Beta 
       variant

<220>
<221>  MISC_FEATURE
<222>  (229)..(234)

<400>  4

Ala Ser Arg Val Gln Pro Thr Glu Ser Ile Val Arg Phe Pro Asn Ile 
1               5                   10                  15      


Thr Asn Leu Cys Pro Phe Gly Glu Val Phe Asn Ala Thr Arg Phe Ala 
            20                  25                  30          


Ser Val Tyr Ala Trp Asn Arg Lys Arg Ile Ser Asn Cys Val Ala Asp 
        35                  40                  45              


Tyr Ser Val Leu Tyr Asn Ser Ala Ser Phe Ser Thr Phe Lys Cys Tyr 
    50                  55                  60                  


Gly Val Ser Pro Thr Lys Leu Asn Asp Leu Cys Phe Thr Asn Val Tyr 
65                  70                  75                  80  


Ala Asp Ser Phe Val Ile Arg Gly Asp Glu Val Arg Gln Ile Ala Pro 
                85                  90                  95      


Gly Gln Thr Gly Asn Ile Ala Asp Tyr Asn Tyr Lys Leu Pro Asp Asp 
            100                 105                 110         


Phe Thr Gly Cys Val Ile Ala Trp Asn Ser Asn Asn Leu Asp Ser Lys 
        115                 120                 125             


Val Gly Gly Asn Tyr Asn Tyr Leu Tyr Arg Leu Phe Arg Lys Ser Asn 
    130                 135                 140                 


Leu Lys Pro Phe Glu Arg Asp Ile Ser Thr Glu Ile Tyr Gln Ala Gly 
145                 150                 155                 160 


Ser Thr Pro Cys Asn Gly Val Lys Gly Phe Asn Cys Tyr Phe Pro Leu 
                165                 170                 175     


Gln Ser Tyr Gly Phe Gln Pro Thr Tyr Gly Val Gly Tyr Gln Pro Tyr 
            180                 185                 190         


Arg Val Val Val Leu Ser Phe Glu Leu Leu His Ala Pro Ala Thr Val 
        195                 200                 205             


Cys Gly Pro Lys Lys Ser Thr Asn Leu Val Lys Asn Lys Cys Val Asn 
    210                 215                 220                 


Phe Gly Ser Gly His His His His His His 
225                 230                 


<210>  5
<211>  234
<212>  PRT
<213>  artificial sequence

<220>
<223>  Chemcially synthesized


<220>
<221>  MISC_FEATURE
<222>  (1)..(2)

<220>
<221>  DOMAIN
<222>  (3)..(228)
<223>  SARS CoV-2 Spike protein receptor binding domain from Gamma 
       variant

<220>
<221>  MISC_FEATURE
<222>  (229)..(234)

<400>  5

Ala Ser Arg Val Gln Pro Thr Glu Ser Ile Val Arg Phe Pro Asn Ile 
1               5                   10                  15      


Thr Asn Leu Cys Pro Phe Gly Glu Val Phe Asn Ala Thr Arg Phe Ala 
            20                  25                  30          


Ser Val Tyr Ala Trp Asn Arg Lys Arg Ile Ser Asn Cys Val Ala Asp 
        35                  40                  45              


Tyr Ser Val Leu Tyr Asn Ser Ala Ser Phe Ser Thr Phe Lys Cys Tyr 
    50                  55                  60                  


Gly Val Ser Pro Thr Lys Leu Asn Asp Leu Cys Phe Thr Asn Val Tyr 
65                  70                  75                  80  


Ala Asp Ser Phe Val Ile Arg Gly Asp Glu Val Arg Gln Ile Ala Pro 
                85                  90                  95      


Gly Gln Thr Gly Thr Ile Ala Asp Tyr Asn Tyr Lys Leu Pro Asp Asp 
            100                 105                 110         


Phe Thr Gly Cys Val Ile Ala Trp Asn Ser Asn Asn Leu Asp Ser Lys 
        115                 120                 125             


Val Gly Gly Asn Tyr Asn Tyr Leu Tyr Arg Leu Phe Arg Lys Ser Asn 
    130                 135                 140                 


Leu Lys Pro Phe Glu Arg Asp Ile Ser Thr Glu Ile Tyr Gln Ala Gly 
145                 150                 155                 160 


Ser Thr Pro Cys Asn Gly Val Lys Gly Phe Asn Cys Tyr Phe Pro Leu 
                165                 170                 175     


Gln Ser Tyr Gly Phe Gln Pro Thr Tyr Gly Val Gly Tyr Gln Pro Tyr 
            180                 185                 190         


Arg Val Val Val Leu Ser Phe Glu Leu Leu His Ala Pro Ala Thr Val 
        195                 200                 205             


Cys Gly Pro Lys Lys Ser Thr Asn Leu Val Lys Asn Lys Cys Val Asn 
    210                 215                 220                 


Phe Gly Ser Gly His His His His His His 
225                 230                 


<210>  6
<211>  234
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Chemically synthesized


<220>
<221>  MISC_FEATURE
<222>  (1)..(2)

<220>
<221>  DOMAIN
<222>  (3)..(228)
<223>  SARS Co-V Spike protein receptor binding domain from Delta 
       variant

<220>
<221>  MISC_FEATURE
<222>  (229)..(234)

<400>  6

Ala Ser Arg Val Gln Pro Thr Glu Ser Ile Val Arg Phe Pro Asn Ile 
1               5                   10                  15      


Thr Asn Leu Cys Pro Phe Gly Glu Val Phe Asn Ala Thr Arg Phe Ala 
            20                  25                  30          


Ser Val Tyr Ala Trp Asn Arg Lys Arg Ile Ser Asn Cys Val Ala Asp 
        35                  40                  45              


Tyr Ser Val Leu Tyr Asn Ser Ala Ser Phe Ser Thr Phe Lys Cys Tyr 
    50                  55                  60                  


Gly Val Ser Pro Thr Lys Leu Asn Asp Leu Cys Phe Thr Asn Val Tyr 
65                  70                  75                  80  


Ala Asp Ser Phe Val Ile Arg Gly Asp Glu Val Arg Gln Ile Ala Pro 
                85                  90                  95      


Gly Gln Thr Gly Lys Ile Ala Asp Tyr Asn Tyr Lys Leu Pro Asp Asp 
            100                 105                 110         


Phe Thr Gly Cys Val Ile Ala Trp Asn Ser Asn Asn Leu Asp Ser Lys 
        115                 120                 125             


Val Gly Gly Asn Tyr Asn Tyr Arg Tyr Arg Leu Phe Arg Lys Ser Asn 
    130                 135                 140                 


Leu Lys Pro Phe Glu Arg Asp Ile Ser Thr Glu Ile Tyr Gln Ala Gly 
145                 150                 155                 160 


Ser Lys Pro Cys Asn Gly Val Glu Gly Phe Asn Cys Tyr Phe Pro Leu 
                165                 170                 175     


Gln Ser Tyr Gly Phe Gln Pro Thr Asn Gly Val Gly Tyr Gln Pro Tyr 
            180                 185                 190         


Arg Val Val Val Leu Ser Phe Glu Leu Leu His Ala Pro Ala Thr Val 
        195                 200                 205             


Cys Gly Pro Lys Lys Ser Thr Asn Leu Val Lys Asn Lys Cys Val Asn 
    210                 215                 220                 


Phe Gly Ser Gly His His His His His His 
225                 230                 


<210>  7
<211>  2046
<212>  DNA
<213>  artificial sequence

<220>
<223>  chemically synthesized


<220>
<221>  cDNA
<222>  (1)..(2046)
<223>  SARS CoV2 S1 Domain cDNA

<400>  7
agccagtgcg tcaatctgac aactcggact cagctgccac ctgcttatac taatagcttc       60

accagaggcg tgtactatcc tgacaaggtg tttagaagct ccgtgctgca ctctacacag      120

gatctgtttc tgccattctt tagcaacgtg acctggttcc acgccatcca cgtgagcggc      180

accaatggca caaagcggtt cgacaatccc gtgctgcctt ttaacgatgg cgtgtacttc      240

gcctctaccg agaagagcaa catcatcaga ggctggatct ttggcaccac actggactcc      300

aagacacagt ctctgctgat cgtgaacaat gccaccaacg tggtcatcaa ggtgtgcgag      360

ttccagtttt gtaatgatcc cttcctgggc gtgtactatc acaagaacaa taagagctgg      420

atggagtccg agtttagagt gtattctagc gccaacaact gcacatttga gtacgtgagc      480

cagcctttcc tgatggacct ggagggcaag cagggcaatt tcaagaacct gagggagttc      540

gtgtttaaga atatcgacgg ctacttcaaa atctactcta agcacacccc catcaacctg      600

gtgcgcgacc tgcctcaggg cttcagcgcc ctggagcccc tggtggatct gcctatcggc      660

atcaacatca cccggtttca gacactgctg gccctgcaca gaagctacct gacacccggc      720

gactcctcta gcggatggac cgccggcgct gccgcctact atgtgggcta cctccagccc      780

cggaccttcc tgctgaagta caacgagaat ggcaccatca cagacgcagt ggattgcgcc      840

ctggaccccc tgagcgagac aaagtgtaca ctgaagtcct ttaccgtgga gaagggcatc      900

tatcagacat ccaatttcag ggtgcagcca accgagtcta tcgtgcgctt tcctaatatc      960

acaaacctgt gcccatttgg cgaggtgttc aacgcaaccc gcttcgccag cgtgtacgcc     1020

tggaatagga agcggatcag caactgcgtg gccgactata gcgtgctgta caactccgcc     1080

tctttcagca cctttaagtg ctatggcgtg tcccccacaa agctgaatga cctgtgcttt     1140

accaacgtct acgccgattc tttcgtgatc aggggcgacg aggtgcgcca gatcgccccc     1200

ggccagacag gcaagatcgc agactacaat tataagctgc cagacgattt caccggctgc     1260

gtgatcgcct ggaacagcaa caatctggat tccaaagtgg gcggcaacta caattatctg     1320

taccggctgt ttagaaagag caatctgaag cccttcgaga gggacatctc tacagaaatc     1380

taccaggccg gcagcacccc ttgcaatggc gtggagggct ttaactgtta tttcccactc     1440

cagtcctacg gcttccagcc cacaaacggc gtgggctatc agccttaccg cgtggtggtg     1500

ctgagctttg agctgctgca cgccccagca acagtgtgcg gccccaagaa gtccaccaat     1560

ctggtgaaga acaagtgcgt gaacttcaac ttcaacggcc tgaccggcac aggcgtgctg     1620

accgagtcca acaagaagtt cctgccattt cagcagttcg gcagggacat cgcagatacc     1680

acagacgccg tgcgcgaccc acagaccctg gagatcctgg acatcacacc ctgctctttc     1740

ggcggcgtga gcgtgatcac acccggcacc aatacaagca accaggtggc cgtgctgtat     1800

caggacgtga attgtaccga ggtgcccgtg gctatccacg ccgatcagct gaccccaaca     1860

tggcgggtgt acagcaccgg ctccaacgtc ttccagacaa gagccggatg cctgatcgga     1920

gcagagcacg tgaacaattc ctatgagtgc gacatcccaa tcggcgccgg catctgtgcc     1980

tcttaccaga cccagacaaa ctctcccaga agagcccggg gatccggcca ccatcaccat     2040

caccac                                                                2046


<210>  8
<211>  679
<212>  PRT
<213>  artificial sequence

<220>
<223>  Chemically synthesized


<220>
<221>  MISC_FEATURE
<222>  (1)..(2)

<220>
<221>  DOMAIN
<222>  (2)..(673)
<223>  SARS CoV-2 S1 Domain from Wuhan variant

<400>  8

Ala Ser Gln Cys Val Asn Leu Thr Thr Arg Thr Gln Leu Pro Pro Ala 
1               5                   10                  15      


Tyr Thr Asn Ser Phe Thr Arg Gly Val Tyr Tyr Pro Asp Lys Val Phe 
            20                  25                  30          


Arg Ser Ser Val Leu His Ser Thr Gln Asp Leu Phe Leu Pro Phe Phe 
        35                  40                  45              


Ser Asn Val Thr Trp Phe His Ala Ile His Val Ser Gly Thr Asn Gly 
    50                  55                  60                  


Thr Lys Arg Phe Asp Asn Pro Val Leu Pro Phe Asn Asp Gly Val Tyr 
65                  70                  75                  80  


Phe Ala Ser Thr Glu Lys Ser Asn Ile Ile Arg Gly Trp Ile Phe Gly 
                85                  90                  95      


Thr Thr Leu Asp Ser Lys Thr Gln Ser Leu Leu Ile Val Asn Asn Ala 
            100                 105                 110         


Thr Asn Val Val Ile Lys Val Cys Glu Phe Gln Phe Cys Asn Asp Pro 
        115                 120                 125             


Phe Leu Gly Val Tyr Tyr His Lys Asn Asn Lys Ser Trp Met Glu Ser 
    130                 135                 140                 


Glu Phe Arg Val Tyr Ser Ser Ala Asn Asn Cys Thr Phe Glu Tyr Val 
145                 150                 155                 160 


Ser Gln Pro Phe Leu Met Asp Leu Glu Gly Lys Gln Gly Asn Phe Lys 
                165                 170                 175     


Asn Leu Arg Glu Phe Val Phe Lys Asn Ile Asp Gly Tyr Phe Lys Ile 
            180                 185                 190         


Tyr Ser Lys His Thr Pro Ile Asn Leu Val Arg Asp Leu Pro Gln Gly 
        195                 200                 205             


Phe Ser Ala Leu Glu Pro Leu Val Asp Leu Pro Ile Gly Ile Asn Ile 
    210                 215                 220                 


Thr Arg Phe Gln Thr Leu Leu Ala Leu His Arg Ser Tyr Leu Thr Pro 
225                 230                 235                 240 


Gly Asp Ser Ser Ser Gly Trp Thr Ala Gly Ala Ala Ala Tyr Tyr Val 
                245                 250                 255     


Gly Tyr Leu Gln Pro Arg Thr Phe Leu Leu Lys Tyr Asn Glu Asn Gly 
            260                 265                 270         


Thr Ile Thr Asp Ala Val Asp Cys Ala Leu Asp Pro Leu Ser Glu Thr 
        275                 280                 285             


Lys Cys Thr Leu Lys Ser Phe Thr Val Glu Lys Gly Ile Tyr Gln Thr 
    290                 295                 300                 


Ser Asn Phe Arg Val Gln Pro Thr Glu Ser Ile Val Arg Phe Pro Asn 
305                 310                 315                 320 


Ile Thr Asn Leu Cys Pro Phe Gly Glu Val Phe Asn Ala Thr Arg Phe 
                325                 330                 335     


Ala Ser Val Tyr Ala Trp Asn Arg Lys Arg Ile Ser Asn Cys Val Ala 
            340                 345                 350         


Asp Tyr Ser Val Leu Tyr Asn Ser Ala Ser Phe Ser Thr Phe Lys Cys 
        355                 360                 365             


Tyr Gly Val Ser Pro Thr Lys Leu Asn Asp Leu Cys Phe Thr Asn Val 
    370                 375                 380                 


Tyr Ala Asp Ser Phe Val Ile Arg Gly Asp Glu Val Arg Gln Ile Ala 
385                 390                 395                 400 


Pro Gly Gln Thr Gly Lys Ile Ala Asp Tyr Asn Tyr Lys Leu Pro Asp 
                405                 410                 415     


Asp Phe Thr Gly Cys Val Ile Ala Trp Asn Ser Asn Asn Leu Asp Ser 
            420                 425                 430         


Lys Val Gly Gly Asn Tyr Asn Tyr Leu Tyr Arg Leu Phe Arg Lys Ser 
        435                 440                 445             


Asn Leu Lys Pro Phe Glu Arg Asp Ile Ser Thr Glu Ile Tyr Gln Ala 
    450                 455                 460                 


Gly Ser Thr Pro Cys Asn Gly Val Glu Gly Phe Asn Cys Tyr Phe Pro 
465                 470                 475                 480 


Leu Gln Ser Tyr Gly Phe Gln Pro Thr Asn Gly Val Gly Tyr Gln Pro 
                485                 490                 495     


Tyr Arg Val Val Val Leu Ser Phe Glu Leu Leu His Ala Pro Ala Thr 
            500                 505                 510         


Val Cys Gly Pro Lys Lys Ser Thr Asn Leu Val Lys Asn Lys Cys Val 
        515                 520                 525             


Asn Phe Asn Phe Asn Gly Leu Thr Gly Thr Gly Val Leu Thr Glu Ser 
    530                 535                 540                 


Asn Lys Lys Phe Leu Pro Phe Gln Gln Phe Gly Arg Asp Ile Ala Asp 
545                 550                 555                 560 


Thr Thr Asp Ala Val Arg Asp Pro Gln Thr Leu Glu Ile Leu Asp Ile 
                565                 570                 575     


Thr Pro Cys Ser Phe Gly Gly Val Ser Val Ile Thr Pro Gly Thr Asn 
            580                 585                 590         


Thr Ser Asn Gln Val Ala Val Leu Tyr Gln Asp Val Asn Cys Thr Glu 
        595                 600                 605             


Val Pro Val Ala Ile His Ala Asp Gln Leu Thr Pro Thr Trp Arg Val 
    610                 615                 620                 


Tyr Ser Thr Gly Ser Asn Val Phe Gln Thr Arg Ala Gly Cys Leu Ile 
625                 630                 635                 640 


Gly Ala Glu His Val Asn Asn Ser Tyr Glu Cys Asp Ile Pro Ile Gly 
                645                 650                 655     


Ala Gly Ile Cys Ala Ser Tyr Gln Thr Gln Thr Asn Ser Pro Gly Ser 
            660                 665                 670         


Gly His His His His His His 
        675                 


<210>  9
<211>  677
<212>  PRT
<213>  artificial sequence

<220>
<223>  Chemically synthesized


<220>
<221>  MISC_FEATURE
<222>  (1)..(2)

<220>
<221>  DOMAIN
<222>  (3)..(671)
<223>  SARS-CoV-2 S1 Domain from Delta Variant

<220>
<221>  MISC_FEATURE
<222>  (672)..(677)

<400>  9

Ala Ser Gln Cys Val Asn Leu Arg Thr Arg Thr Gln Leu Pro Pro Ala 
1               5                   10                  15      


Tyr Thr Asn Ser Phe Thr Arg Gly Val Tyr Tyr Pro Asp Lys Val Phe 
            20                  25                  30          


Arg Ser Ser Val Leu His Ser Thr Gln Asp Leu Phe Leu Pro Phe Phe 
        35                  40                  45              


Ser Asn Val Thr Trp Phe His Ala Ile His Val Ser Gly Thr Asn Gly 
    50                  55                  60                  


Thr Lys Arg Phe Asp Asn Pro Val Leu Pro Phe Asn Asp Gly Val Tyr 
65                  70                  75                  80  


Phe Ala Ser Thr Glu Lys Ser Asn Ile Ile Arg Gly Trp Ile Phe Gly 
                85                  90                  95      


Thr Thr Leu Asp Ser Lys Thr Gln Ser Leu Leu Ile Val Asn Asn Ala 
            100                 105                 110         


Thr Asn Val Val Ile Lys Val Cys Glu Phe Gln Phe Cys Asn Asp Pro 
        115                 120                 125             


Phe Leu Asp Val Tyr Tyr His Lys Asn Asn Lys Ser Trp Met Glu Ser 
    130                 135                 140                 


Gly Val Tyr Ser Ser Ala Asn Asn Cys Thr Phe Glu Tyr Val Ser Gln 
145                 150                 155                 160 


Pro Phe Leu Met Asp Leu Glu Gly Lys Gln Gly Asn Phe Lys Asn Leu 
                165                 170                 175     


Arg Glu Phe Val Phe Lys Asn Ile Asp Gly Tyr Phe Lys Ile Tyr Ser 
            180                 185                 190         


Lys His Thr Pro Ile Asn Leu Val Arg Asp Leu Pro Gln Gly Phe Ser 
        195                 200                 205             


Ala Leu Glu Pro Leu Val Asp Leu Pro Ile Gly Ile Asn Ile Thr Arg 
    210                 215                 220                 


Phe Gln Thr Leu Leu Ala Leu His Arg Ser Tyr Leu Thr Pro Gly Asp 
225                 230                 235                 240 


Ser Ser Ser Gly Trp Thr Ala Gly Ala Ala Ala Tyr Tyr Val Gly Tyr 
                245                 250                 255     


Leu Gln Pro Arg Thr Phe Leu Leu Lys Tyr Asn Glu Asn Gly Thr Ile 
            260                 265                 270         


Thr Asp Ala Val Asp Cys Ala Leu Asp Pro Leu Ser Glu Thr Lys Cys 
        275                 280                 285             


Thr Leu Lys Ser Phe Thr Val Glu Lys Gly Ile Tyr Gln Thr Ser Asn 
    290                 295                 300                 


Phe Arg Val Gln Pro Thr Glu Ser Ile Val Arg Phe Pro Asn Ile Thr 
305                 310                 315                 320 


Asn Leu Cys Pro Phe Gly Glu Val Phe Asn Ala Thr Arg Phe Ala Ser 
                325                 330                 335     


Val Tyr Ala Trp Asn Arg Lys Arg Ile Ser Asn Cys Val Ala Asp Tyr 
            340                 345                 350         


Ser Val Leu Tyr Asn Ser Ala Ser Phe Ser Thr Phe Lys Cys Tyr Gly 
        355                 360                 365             


Val Ser Pro Thr Lys Leu Asn Asp Leu Cys Phe Thr Asn Val Tyr Ala 
    370                 375                 380                 


Asp Ser Phe Val Ile Arg Gly Asp Glu Val Arg Gln Ile Ala Pro Gly 
385                 390                 395                 400 


Gln Thr Gly Lys Ile Ala Asp Tyr Asn Tyr Lys Leu Pro Asp Asp Phe 
                405                 410                 415     


Thr Gly Cys Val Ile Ala Trp Asn Ser Asn Asn Leu Asp Ser Lys Val 
            420                 425                 430         


Gly Gly Asn Tyr Asn Tyr Arg Tyr Arg Leu Phe Arg Lys Ser Asn Leu 
        435                 440                 445             


Lys Pro Phe Glu Arg Asp Ile Ser Thr Glu Ile Tyr Gln Ala Gly Ser 
    450                 455                 460                 


Lys Pro Cys Asn Gly Val Glu Gly Phe Asn Cys Tyr Phe Pro Leu Gln 
465                 470                 475                 480 


Ser Tyr Gly Phe Gln Pro Thr Asn Gly Val Gly Tyr Gln Pro Tyr Arg 
                485                 490                 495     


Val Val Val Leu Ser Phe Glu Leu Leu His Ala Pro Ala Thr Val Cys 
            500                 505                 510         


Gly Pro Lys Lys Ser Thr Asn Leu Val Lys Asn Lys Cys Val Asn Phe 
        515                 520                 525             


Asn Phe Asn Gly Leu Thr Gly Thr Gly Val Leu Thr Glu Ser Asn Lys 
    530                 535                 540                 


Lys Phe Leu Pro Phe Gln Gln Phe Gly Arg Asp Ile Ala Asp Thr Thr 
545                 550                 555                 560 


Asp Ala Val Arg Asp Pro Gln Thr Leu Glu Ile Leu Asp Ile Thr Pro 
                565                 570                 575     


Cys Ser Phe Gly Gly Val Ser Val Ile Thr Pro Gly Thr Asn Thr Ser 
            580                 585                 590         


Asn Gln Val Ala Val Leu Tyr Gln Gly Val Asn Cys Thr Glu Val Pro 
        595                 600                 605             


Val Ala Ile His Ala Asp Gln Leu Thr Pro Thr Trp Arg Val Tyr Ser 
    610                 615                 620                 


Thr Gly Ser Asn Val Phe Gln Thr Arg Ala Gly Cys Leu Ile Gly Ala 
625                 630                 635                 640 


Glu His Val Asn Asn Ser Tyr Glu Cys Asp Ile Pro Ile Gly Ala Gly 
                645                 650                 655     


Ile Cys Ala Ser Tyr Gln Thr Gln Thr Asn Ser Arg Gly Ser Gly His 
            660                 665                 670         


His His His His His 
        675         


